Cell Cycle/Checkpoint
Cell Cycle/Checkpoint(细胞周期/检查点)
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0. read more
- ATM/ATR(29)
- Aurora Kinase(58)
- Cdc42(4)
- Cdc7(3)
- Chk(14)
- c-Myc(27)
- CRM1(8)
- Cyclin-Dependent Kinases(77)
- E1 enzyme(1)
- G-quadruplex(12)
- Haspin(6)
- HMTase(1)
- Kinesin(27)
- Ksp(4)
- Microtubule/Tubulin(257)
- Mps1(15)
- Mitotic(7)
- RAD51(13)
- ROCK(74)
- Rho(13)
- PERK(11)
- PLK(43)
- PTEN(6)
- Wee1(9)
- PAK(25)
- Arp2/3 Complex(8)
- Dynamin(14)
- ECM & Adhesion Molecules(54)
- Cytoskeleton & Motor Proteins(65)
- Endomembrane System & Vesicular Trafficking(36)
- G1(51)
- Genotoxic Stress(23)
- G2/M(40)
- G2/S(17)
- Inositol Phosphates(67)
- Proteolysis(183)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(1)
- MARK(3)
- NEKs(1)
Cell Cycle/Checkpoint 相关产品(1379)
- GC14806Vinorelbine ditartrateCAS: 125317-39-7纯度: >98.00%
Vinorelbine ditartrate是一种抗有丝分裂药物,是紫杉醇(Paclitaxel)的一种半合成衍生物,通过抑制肿瘤细胞的微管聚合来发挥抗肿瘤作用,主要用于治疗非小细胞肺癌和转移性乳腺癌等恶性肿瘤。
- GC14807Fingolimod (FTY720) HClCAS: 162359-56-0纯度: >99.50% / >99.00%
芬戈莫德(FTY720)是一种免疫抑制剂,通常用于治疗多发性硬化症,也有抗癌作用,可以作为HDACi(组蛋白脱乙酰酶抑制剂)。
- GC150842-Methoxyestradiol (2-MeOE2)CAS: 362-07-2纯度: >99.50% / >98.00%
2-Methoxyestradiol (2-MeOE2/2-Me)是一种HIF-1α抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14230 | K03861 | 853299-07-7 | >98.00% | |
K03861 (K03861) 是一种 II 型 CDK2 抑制剂,Kd 为 8.2 nM。 K03861 (K03861) 通过与活化细胞周期蛋白的结合竞争抑制 CDK2 活性。 | ||||
| GC14288 | KX2-391 | 897016-82-9 | >99.00% | |
A Src kinase inhibitor | ||||
| GC14294 | Cdk1/2 Inhibitor III | 443798-47-8 | >98.50% | |
A cell-permeable inhibitor of Cdk1 and Cdk2 | ||||
| GC14358 | Rigosertib (ON-01910,Estybon) | 1225497-78-8 | - | |
A potent inhibitor of Plk1 | ||||
| GC14413 | KJ Pyr 9 | 581073-80-5 | >99.00% | |
An inhibitor of c-Myc and v-Myc interaction with Max | ||||
| GC14497 | (S)-CCG-1423 | 2319939-24-5 | - | |
A stereoisomer of CCG-1423, a Rho inhibitor | ||||
| GC14589 | KF 38789 | 257292-29-8 | >98.00% | |
KF 38789是一种新型的低分子量P选择素抑制剂,IC 50 为1.97μM。 | ||||
| GC14592 | KW 2449 | 1000669-72-6 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC14600 | SB743921 | 940929-33-9 | >98.00% | |
An Eg5 inhibitor | ||||
| GC14644 | SBE 13 HCl | 1052532-15-6 | >98.50% | |
A potent Plk1 inhibitor | ||||
| GC14650 | CGP60474 | 164658-13-3 | >98.50% | |
A CDK inhibitor | ||||
| GC14707 | Purvalanol A | 212844-53-6 | >99.00% | |
A selective inhibitor of cyclin-dependent kinases | ||||
| GC14772 | CCT244747 | 1404095-34-6 | >99.00% | |
A potent Chk1 inhibitor | ||||
| GC14806 | Vinorelbine ditartrate | 125317-39-7 | >98.00% | |
Vinorelbine ditartrate是一种抗有丝分裂药物,是紫杉醇(Paclitaxel)的一种半合成衍生物,通过抑制肿瘤细胞的微管聚合来发挥抗肿瘤作用,主要用于治疗非小细胞肺癌和转移性乳腺癌等恶性肿瘤。 | ||||
| GC14807 | Fingolimod (FTY720) HCl | 162359-56-0 | >99.50% / >99.00% | |
芬戈莫德(FTY720)是一种免疫抑制剂,通常用于治疗多发性硬化症,也有抗癌作用,可以作为HDACi(组蛋白脱乙酰酶抑制剂)。 | ||||
| GC14857 | LFM-A13 | 244240-24-2 | >99.50% | |
A BTK inhibitor | ||||
| GC14918 | 10074-G5 | 413611-93-5 | - | |
An inhibitor of c-Myc/Max dimerization | ||||
| GC14929 | Monastrol | 254753-54-3;329689-23-8 | >99.50% | |
Monastrol是一种强效且具细胞通透性的有丝分裂驱动蛋白Eg5抑制剂,其 IC 50 为14μM。 | ||||
| GC14986 | CCG-100602 | 1207113-88-9 | >99.50% | |
A Rho/MKL1 transcriptional pathway inhibitor | ||||
| GC15047 | PHA-793887 | 718630-59-2 | >98.00% | |
A CDK inhibitor | ||||
| GC15076 | CK 869 | 388592-44-7 | >99.50% | |
An inhibitor of the Arp2/3 complex | ||||
| GC15084 | 2-Methoxyestradiol (2-MeOE2) | 362-07-2 | >99.50% / >98.00% | |
2-Methoxyestradiol (2-MeOE2/2-Me)是一种HIF-1α抑制剂。 | ||||
| GC15170 | SB 772077B dihydrochloride | 607373-46-6 | >98.50% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC15171 | Ac-LEVD-AFC | 1092077-23-0 | - | |
A fluorogenic substrate for caspase-4 | ||||
